Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Peptide-based anticancer vaccine J-65 induces tumor cell lysis

April 15, 2013

Amorfix Life Sciences reveals latest tumor study findings

April 11, 2013

Preclinical development of an anticancer antibody with a unique mechanism of action

April 11, 2013

Bavarian Nordic plans interim analysis of PROSPECT trial

April 10, 2013

Dainippon Sumitomo and Chugai agree to terminate joint development of anticancer vaccine candidates

April 9, 2013

Alligator Bioscience and BioInvent International design new antibodies for cancer

April 5, 2013

Imperial Innovations researchers describe anti-DDR1 antibodies

April 4, 2013

Daratumumab granted FDA fast track designation

April 4, 2013

CureVac commences phase IIb trial of mRNA-based prostate cancer vaccine

April 2, 2013

Arzerra approved in Japan

March 26, 2013

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026